Related Experiment Video
Updated: Aug 5, 2026

Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
Fresh Phytomedicines: Traditional Applications, Chemical Composition, Pharmacological Activities, Challenges, and
Yifan Zeng1, Kanglin Bai1, Jianhong Xie1
1College of Pharmaceutical Science, Dali University, Dali 671000, China.
Abstract:
Fresh phytomedicines (FPs), defined as medicinal plants used in their fresh, undried state, have long been applied in traditional medical systems worldwide and represent a diverse yet underexplored source of bioactive compounds derived from classical prescriptions, ethnomedicinal practices, and medicine-food homology plants. Increasing evidence suggests that FPs possess distinct chemical and pharmacological properties compared with dried phytomedicines (DPs), although their therapeutic value has not been systematically evaluated from a modern medical perspective. This review integrates ethnomedicinal knowledge with modern pharmacological evidence to clarify the therapeutic potential of FPs, while comparing them with DPs and evaluating their potential role as context-dependent alternatives or complementary strategies that warrant further clinical investigation. A comprehensive literature search covering the period from 1956 to January 2026 was conducted across Web of Science, PubMed, Scopus, CNKI, ProQuest, and SciELO, followed by bibliometric analysis using VOSviewer 1.6.20. Available evidence indicates that FPs and DPs exhibit distinct physicochemical and pharmacological profiles. Drying enriches thermally stable constituents or leads to the formation of new compounds in DPs, whereas FPs better preserve thermosensitive and labile compounds, including polysaccharides, flavonoids, alkaloids, and volatile oils. These preserved constituents contribute to context-dependent activities such as antimicrobial, antioxidant, antidiabetic, and immunomodulatory effects. Although FPs offer unique therapeutic potential, their application is constrained by instability, limited standardization, inconsistent dosing, and insufficient clinical evidence, and future efforts should focus on improved preservation technologies, comprehensive quality standards, systematic dosage studies, and well-designed clinical trials to substantiate their clinical applicability and facilitate evidence-based integration into modern therapeutic frameworks.
Related Concept Videos
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Effects of Chemicals: Overview
Pharmaceutical Poisoning: Treatment Strategies
Drug Discovery: Overview
Site-Targeted Drug Delivery Systems: Polymeric Carriers
